Related Experiment Videos
[Association between post-initial remission and HLA phenotype in Type I diabetics]
R V García-Mayor1, A Andrade, M del Pozo
1Sección de Endocrinología, Hospital Xeral de Vigo.
Anales De Medicina Interna (Madrid, Spain : 1984)
|July 1, 1992
Summary
The study found that 12% of type I diabetics achieved complete remission and 30% partial remission. Remission rates were linked to the presence of the HLA-DR4 antigen, suggesting a genetic component in type I diabetes.
Area of Science:
- Immunogenetics
- Endocrinology
- Clinical Medicine
Context:
- Type I diabetes (DMI) is an autoimmune disease characterized by pancreatic beta-cell destruction.
- Understanding factors influencing disease remission is crucial for managing DMI.
- The role of human leukocyte antigen (HLA) phenotypes in DMI prognosis requires further investigation.
Purpose:
- To estimate the occurrence rate of post-initial remission in type I diabetics.
- To investigate the association between HLA phenotype and remission in type I diabetes.
- To explore potential clinical-immunological heterogeneity in DMI.
Summary:
- Fifty type I diabetics were studied for remission rates and HLA phenotypes.
- Remission (complete or partial) was observed in 12% and 30% of patients, respectively.
- A significantly higher incidence of HLA-DR4 antigen was found in patients with remission (61.9%) compared to those without (20%, p<0.5).
Impact:
- Results suggest a genetically determined clinical-immunological heterogeneity in type I diabetes.
- The findings highlight the potential role of the HLA system in DMI remission.
- This research supports the need for personalized approaches in DMI management based on genetic factors.